Research Bench Lab

Yu Laboratory

Microbiology & Immunology
BSB B2325

General Interests
Tumor Immunology, Cancer Immunotherapy, Hematopoietic Cell Transplantation, Graft-versus-Host Disease, Graft-versus-Leukemia Effect

View Xue-Zhong Yu bio
Xue-Zhong Yu Laboratory

Research Areas

The research scope of Dr. Yu’s laboratory (Yu Lab) is in tumor immunology and cancer immunotherapy. The researchers in Yu’s Lab have been focusing on two lines of basic and translational studies:

Allogeneic Hematopoietic Cell Transplantation (allo-HCT). Acting through donor lymphocyte-mediated mechanisms termed the graft-versus-leukemia (GVL) effect, allo-HCT is an effective therapy for hematological malignancies such as leukemia. However, graft-versus-host disease (GVHD) remains a prominent cause of transplant-related morbidity and mortality after allo-HCT. Despite advances in patient care and pharmacologic prophylactic strategies, the incidence of GVHD, especially cGVHD, has not been substantially reduced over the years. Furthermore, corticosteroids remain as the first line therapy for GVHD and frequently fail with life-threatening consequences. Yu Lab focuses on defining the cellular and molecular mechanisms that regulate the pathogenicity of allogeneic T and B cells in GVHD, and on developing new and effective therapies to prevent and treat GVHD.

Adoptive T-cell Therapy (ACT). The adaptive immune system has the capacity to recognize and kill malignant cells. However, immune tolerant mechanisms that normally protect healthy tissues from autoimmune attack prevent the development of effective anti-tumor immunity. Tumors use numerous immunosuppressive mechanisms to evade otherwise effective T-cell responses. Despite promising results achieved by targeting one or more of the immune evasion mechanisms, there is clearly room for improvement because only a subset of cancer patients usually respond to current treatment. Aiming at understanding T-cell response against tumor and promoting anti-tumor activity, Yu Lab is interested in investigating T-cell activation, differentiation, persistence, migration, and metabolism in immunotherapy against cancer.

Test tubes with beaker

Current Members


Reza Alimohammadi, PhD

Postdoctoral Fellow, Yu Lab


Rajdip Basnet

Graduate Student


Qiao Cheng, PhD

Postdoctoral Fellow, Yu Lab


Allison Pugel

Research Technologist, Yu Lab


Linlu Tian, MD, PhD

Postdoctoral Fellow, Yu Lab


Yongxia Wu, MD, PhD

Research Assistant Professor

Recent Publications